March 31, 2025 - 23:41

In a significant leadership move, OMNIA Partners has announced the appointment of Ashish Agarwal as the Executive Vice President of Technology. This strategic decision is aimed at enhancing the organization's technological capabilities and driving innovation within its operations. Agarwal brings a wealth of experience in technology management and digital transformation, having held various leadership positions in the industry.
As the Executive Vice President, Agarwal will oversee the development and implementation of technology strategies that align with OMNIA Partners' mission to deliver value to its members. His expertise will be crucial in advancing the organization’s digital initiatives and improving operational efficiency.
OMNIA Partners continues to solidify its position as a leader in group purchasing by leveraging technology to provide superior services to both public and private sector clients. Agarwal's leadership is expected to play a pivotal role in the organization's ongoing efforts to adapt to the ever-evolving technological landscape.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...